Pacific Edge leads NZ shares higher

Pacific Edge leads NZ shares higher
Kaiser gave the green light to add Cxbladder to its electronic medical records system. (Image: Pacific Edge)
Dan Brunskill
New Zealand's main share index rose on Wednesday after Pacific Edge announced a US healthcare provider would now be able to order its cancer test more quickly and easily.The S&P/NZX 50 Index rose 64.89 points, or 0.6%, to 11,373.24. Turnover was $137 million.Pacific Edge led the market higher, jumping almost 17% to 83 cents, after it announced healthcare giant Kaiser Permanente had given the green light to add Cxbladder to its electronic medical records system.While it may sound technical, this project has been under way for months and...

More Markets

NZ sharemarket up 0.1% on flat trading day
Markets Market close

NZ sharemarket up 0.1% on flat trading day

The S&P/NZX 50 Index closed at 11,790.92, up 14.18 points or 0.12%.

Advent International eyes NZ deals with Aussie outpost
Markets

Advent International eyes NZ deals with Aussie outpost

US private equity giant says NZ key market for growth.

These shares are 'priced for awful'
Markets

These shares are 'priced for awful'

Kathmandu, SkyCity and Fletcher shares are under pressure. Some are taking the plunge.